Moss Adams Wealth Advisors LLC Gilead Sciences, Inc. Transaction History
Moss Adams Wealth Advisors LLC
- $1.1 Trillion
- Q2 2025
A detailed history of Moss Adams Wealth Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Moss Adams Wealth Advisors LLC holds 4,198 shares of GILD stock, worth $473,072. This represents 0.04% of its overall portfolio holdings.
Number of Shares
4,198
Previous 3,700
13.46%
Holding current value
$473,072
Previous $415 Million
12.26%
% of portfolio
0.04%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,330Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$13.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$13.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$6.67 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.22 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.23 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $141B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...